Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
Go back to Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 17.31 -1.16 (6.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.47 | 52 Week High | $11.53 | |||
| Open | $18.61 | 52 Week Low | $4.83 | |||
| Day High | $18.79 | P/E | 5.87 | |||
| Day Low | $17.27 | EPS | $2.95 | |||
| Volume | 3,023,468 | |||||
